While I was in medical school and graduate school, I did dance and musical theater. Here was a great outlet of people who were fun and creative and interesting, and I could be up until 2:00 in the morning building a set or rehearsing for a big performance. But really, the thrill was to have a group of people together working toward a common goal. Which, actually, is not dissimilar to what I like about my job. I have a great team, and we work really well together.

In the ophthalmology group here at Regeneron, we are studying medications to treat retinal diseases that are often blinding. My job is really overarching, from the inception of a program. There's a million different questions you can ask, and you have to figure out a way to make sure that you are testing the most important ones, or you get the clearest answers for the questions that you want.

You design a study, and you pitch it to management, and you get permission to actually do it, and then you actually have to write a protocol, choose and train your investigators, oversee the study from a safety perspective, and then you analyze your data and it all gets dumped onto me and the team, and we spend a lot of time sorting through it, graphing it, figuring out what it means so that we can put it together as part of a story. You're working closely with your team toward a common goal, and similar to the reasons I did theater for all those years, it's really rewarding to be in the trenches, working really hard with a group of people and accomplishing something. My name is Alyson, and I'm a Regeneron scientist.

When I was younger, I loved nature walks with my family, seeing animals and plants that I had never seen before. Where does it get its energy from? How does it work? If you pursue those kind of questions, it ultimately leads to looking at the human body. Imaging science is three-dimensional pictures or even four-dimensional pictures like movies of what's happening inside a person's body.

For instance, looking at the heart and you can see the heart beating in real-time and then do measurements on how that changes. The disease of fibrodysplasia ossificans progressiva that causes uncontrollable bone growth in patients. They grow a secondary skeleton, which immobilizes them over time and causes a premature death. What imaging is doing is actually providing us with an early read of how antibody should be working on these patients.

Whether antibody that we're trying in these patients actually can make a difference in these patients' disease and lives. That potential that we can make someone's life and their family's life better is really what I love most about working here at Regeneron. My name is Dinko and I'm a Regeneron scientist.

I was born into a Greek immigrant family who had come from war torn Greece. My grandfather, he had a remarkable story. He was a freedom fighter. He got caught and sentenced to death, somehow escaped to Vienna, Austria, and he saw electric lights for the first time. It was magic. And though he had no education, he made the decision that he was going to devote himself to understanding this magic. Unbelievably enough, he became an electrical engineer who then brought electricity back to his homeland. So when I was a little kid, I wanted to be a scientist like my grandfather. And as I got a little older, I heard there was a school called the Bronx High School of Science. And once I was there, I decided that I wanted to study the fundamental basis of life and genes as we were beginning to understand it.

It's an incredible honor to be in a world where we do science with the goal of ultimately impacting human beings who suffer from disease. And we're in an incredible position where we get to meet these patients many times and see what a difference something that you've been working on for years and years in the lab that initially was just a really early idea, and maybe it didn't seem that real and that practical, and that it was going to really turn into something, but now many years later, it's actually making a difference in people's lives. And I think that makes you very proud of what Regeneron does, what we spend our lives doing. And I think it gives you a lot of hope for the future. It makes you just want to go back out there and invent and discover the next new treatment to make more of a difference for more patients. My name is George, and I'm Regeneron's chief scientist.

When I was a little girl, I really wanted to design princess dresses. I drew all these princess gowns with these big ball skirts, and fortunately, very fortunately, as I grew up, that desire to design changed to something a little more practical.

I thought about architecture, architectural design. I thought about other kinds of design, but, ultimately what drew me was the challenge that biology posed and still poses. It's such a complex puzzle, and I really love puzzles, and so, I combined that love of design into thinking about a new question and designing an experiment to answer that question, and then, I also get to solve a puzzle by getting the results and interpreting the results.

My name is Jean Siao. I'm a Regeneron scientist.

When I was little, I wanted to be a veterinarian like my dad. My dad told me I was too short to be a zoo veterinarian like him. When I got older, I decided that a medical doctor would be better, because you could explain to patients and make a plan together, and I also realized that verbal communication was a critical part of the healing process.

So, I studied medicine and worked as a practicing oncologist for almost 10 years. It is very humbling. You come in every day and you meet people that are very sick. However, when I come here and I do my work, I hope that I can change the world on a much larger scale. I do miss my clinic patients, but now I have thousands of patients and I can make a difference in the big picture.

The immuno-oncology is actually one of the greatest inventions in oncology. Regeneron develops antibodies that block this mechanism that the cancer uses to put the T cells, which are the cells that fight cancer to sleep. So, the T cells get reactivated and actually beat the cancer. We enable patients to have their immune system fight their cancer. What immuno-oncology does is it outsmarts the cancer. My name is Petra and I'm a Regeneron scientist.

When I was younger, I was still a little guy out there playing football. And I got a lot of injuries. I tore my ACL, broke a bone in my knee, and I really had a remarkable experience with the physicians and how they were able to fix me up and put me back together. And I saw how using skills and training could actually impact people's lives in a positive way, even when things get broken, they can get fixed.

Clinical trial participation is very important. It allows us to see if our compounds are actually useful and effective and safe. My job is to make sure that the clinical trials that we run are done in high quality. We execute the clinical plan that is developed from our scientists and from our physicians. When you have a clinical trial, you need to get approval from different countries. You need to find the patients globally. You need to train the physicians. And you need to collect the data.

So it feels very rewarding to be a part of an organization that is changing the lives of patients with unmet needs. It helps me grow as well. I get to learn new things and actually be a part of building something. My name is Wilson, and I am proud to be a part of Regeneron Science.

I love to build things. As a kid, me and my brother, we always put stuff together and playing those video games that made you think, and you had to figure out how to get to the next step and really kind of problem solve. When I started at Regeneron, I was actually working on the manufacturing floor making our drugs. IOPS is our industrial operations and product supply facility.

I always kind of felt a longing to know the science behind what we were doing. Process sciences helps to support our process of producing our monoclonal antibodies, kind of as a scientific backbone to our production supply facility. There's not a lot of room for error, especially when you're working with biologics and you're working with live cells. They can be impacted by changes in an environment. You really need to have that ideal state for cells. And it's all controlled through automation.

What I do is all about control and detection, repeatability and consistency over time. Our end result is our product. It is our medicine that goes out the door that ultimately will go into a patient. We like challenges. We like to figure out what needs to be done, no matter what it takes. And we will do whatever it takes to get that quality drug out to whoever needs it. My name is ZacK. And I'm proud to be a part of Regeneron Science.